REASONS TO INVEST
TEAM
Forrest Smith • Chief Executive Officer, Co-Founder, Board Member
Aside from his founder position in multiple companies, Forrest has held several positions, from Director of Asian Operations for a Fortune 500 company to Director of Business Development. His education includes International Baccalaureate with a focus on Chinese, Nanjing University/Johns Hopkins Center, and Georgia Tech.
Read More
Thomas Sanderson • Chief Operating Officer, Co-Founder, Board Member
Over 10 years as co-founder of a successful Film Production Studio based out of South East China - providing film services for leading global brands such as Huawei, Sennheiser, Audi, John Lewis...
He firmly believes that incorporating mindfulness, health and well-being into your professional and personal life is the key to success.
Read More
Edward Sanderson • Chief Financial Officer, Board Member
the pitch
Illuminating Lives & Transforming Health
Kineon began with a core mission to empower the largest number of people in the most impactful way, to take ownership of their health and quality of life.
Our light therapy devices provide an effective alternative approach to pharmaceuticals – providing not a band-aid solution, but a genuine shift in how we approach pain relief.
With FDA clearance, 9,000+ units sold, and $3.5M+ in sales, we believe Kineon is quickly becoming one of the most effective solutions for chronic pain on the market.
The Problem & Our solution
The Chronic Pain Epidemic
Chronic pain is a debilitating condition that affects over 20% of adults in the United States, and severely impacts the lives of millions of people every day.
For too long, the answer to chronic pain has been temporary and costly solutions, such as pharmaceuticals, that simply mask the pain without addressing the root cause.
These solutions are not only ineffective but also carry harmful side effects, leaving people trapped in a cycle of pain long-term.
To date, there are now over 6,000 clinical studies showing the benefits of light therapy for a huge variety of conditions, including acute injuries (MCL, ACL, meniscus tear or sprain) as well as inflammatory conditions like osteoarthritis, rheumatoid arthritis, tendinitis, and gout (Source).
Laser therapy has also proven to be very effective post-surgery to speed up recovery (Source | Source).
Affordable At-Home Laser Therapy
Traditional laser therapy devices can cost upwards of $15,000, making them inaccessible to many (Source). Meanwhile, most home-use devices rely solely on LED technology, lacking the penetrating power required for effective tissue targeting.
Alternatives to laser therapy devices typically include costly surgeries, reliance on pharmaceutical drugs, or outdated R.I.C.E methods.
That's why Kineon developed MOVE+ Pro: the next-generation laser therapy device that tackles chronic pain head-on in as little as 5 minutes.
Unlike costly clinical treatments or ineffective home-use devices, MOVE+ Pro bridges the accessibility gap by offering sub-$500 pricing, optimal dosing, and a simple user experience. MOVE+ Pro works by combining LEDs and lasers in a narrower emission field, penetrating deep into the body for optimal dosing.
Our wearable device works in direct contact with the skin, ensuring consistent and effective treatment. With MOVE+ Pro, individuals can manage their pain and inflammation at home, and take control over their health and quality of life.
the market & Our Traction
Bringing Light Therapy Home & Beyond
For decades, the potential of light therapy has been hindered by complex dosing and prohibitive costs. However, the correct dosing has required testing to optimize and the cost to produce laser devices has made it prohibitive for home use until the last 3 years.
Our target market, the chronic pain market is expected to reach $142.5B by 2033 (Source). But thanks to recent advancements in VCSEL lasers, Kineon has created MOVE+, a battery-driven, wearable system that brings the power of light therapy into the comfort of your home.
The market has responded with enthusiasm, as evidenced by our growth, delivering over 9,000 devices worldwide within just 9 months, increasing our monthly revenue to $400K. From September 2022 to May 2023, we saw our sales increase from $80K to $400K. As a consequence, our COGS experienced an increase from $13,452 to $63,784.
*The above testimonials may not be representative of the opinions or of the experiences of other users and is not a guarantee of future performance or success.
The MOVE+ has been endorsed by world-renowned athletes, medical professionals, and biohackers who are getting incredible results, and sharing their journey with millions of people all over the world.
We've partnered with athletes from 6 renowned professional sports leagues including the NFL, Soccer, CrossFit, NBA, MLB, and Rugby, earning support from elite athletes like Sara Sigmundsdottir and Brooke Wells (both Crossfit Games Athletes with 1.8M+ IG followers).
*The above testimonials may not be representative of the opinions or of the experiences of other professional athletes and users and is not a guarantee of future performance or success.
With the medical community's overwhelming support, we've been able to launch a Medical Practitioner Reseller (MPR) program to better reach those who need our product the most.
Our operations have received FDA and FCC clearances, and we've continued to develop and scale our U.S. and ROW warehouses to streamline shipments.
We've already designed and shipped multiple product upgrades since August 2022, and we're now preparing to launch our next cutting-edge product, the Gut+ later this year. This device can be a huge step forward in supporting common gut health-related issues, like IBS, Crohn's and Colitis.
Our next anticipated game-changer, the Brain+, is in the works, which aims to treat a range of common cognitive disorders like anxiety, depression, PTSD, Alzheimer's, and dementia.
*This is a rendering of GUT+ and BRAIN+. Images are computer-generated demo versions. The products are still currently under development and are not yet available on the market.
We aim to expand our reach from the medical community and professional sports leagues, to beyond, transforming lives, one MOVE+ at a time.
Why Invest
Join the MOVE+ment
MOVE+ Pro, is a portable solution designed to deliver clinical dosing with ease and precision, to improve the quality of life for those that need it most.
With world-class laser therapy devices that offer an effective alternative to pharmaceuticals, Kineon is transforming the landscape of red light therapy.
We believe our monthly revenue growth from $80,000 to $400,000 in 9 months speaks volumes about the demand for our innovative solutions.
Supported by FDA clearance and a previous Indiegogo campaign that raised $1.35 million, Kineon is backed by a strong community of users. Glowing reviews and endorsements from professional athletes and leagues further underscore our credibility.
By investing in Kineon, you're not only supporting our mission to develop revolutionary devices, but also investing in a world where pain relief is accessible and life-changing for everyone.
We're inviting you to be a part of this journey and share in the success of a product that is transforming the way we approach chronic pain.
ABOUT
HEADQUARTERS
4840 Rebel Trail
Atlanta, GA 30327
WEBSITE
View Site
TERMS
Overview
PRICE PER SHARE
DEADLINE
May. 14, 2025 at 3:09 AM UTC
VALUATION
Breakdown
MIN INVESTMENT
MAX INVESTMENT
OFFERING TYPE
Maximum Number of Shares Offered subject to adjustment for bonus shares
ALL UPDATES
REWARDS
JOIN THE DISCUSSION
0/2500
Léa Bouhelier-Gautreau
2 years ago
Hi! Could you please tell us your burn rate and your cash on hand?
1
0
Sherwood Neiss
2 years ago
Hello Kineon Team, I represent D3VC, a venture fund that specializes in equity crowdfunding deals. We’ve taken a keen interest in your offering on StartEngine. As part of our due diligence process, we have a couple of questions: With the ever-evolving landscape of your industry, how does Kineon plan to differentiate itself from existing competitors and maintain a competitive edge? We’re curious about your distribution strategy. Could you shed some light on where you intend to perform distribution and any partnerships or channels you’re considering? We appreciate your time and look forward to understanding more about your venture.
Show more
1
0
Michael Deuker
2 years ago
Are you allowed to tell us which pro athletes have endorsed or backed your product?
1
0
Jorge Filevich
2 years ago
Where is the clinical trials that you talk about? Can you provide copies of the publications?
1
0
Grigore Hreniuc
2 years ago
There are tons of infrared lights therapy for pain relief on Ebay, Amazon.. sells for $25-$100. What's makes your device different?
Show more
1
0
Leonard Borusky
2 years ago
Is there a timeline for releasing future projects such as the Gut+? When can we expect to see those projects hit market?
Show more
1
0
W Kim Colich
2 years ago
Hi, Does Kineon have any Patents secured for this technology? Thanks. Blessings
1
0
HOW INVESTING WORKS
Cancel anytime before 48 hours before a rolling close or the offering end date.
WHY STARTENGINE?
REWARDS
We want you to succeed and get the most out of your money by offering rewards and memberships!
SECURE
Your info is your info. We take pride in keeping it that way!
DIVERSE INVESTMENTS
Invest in over 200 start-ups and collectibles!
FAQS
With Regulation A+, a non-accredited investor can only invest a maximum of 10% of their annual income or 10% of their net worth per year, whichever is greater. There are no restrictions for accredited investors.
With Regulation Crowdfunding, non-accredited investors with an annual income or net worth less than $124,000 are limited to invest a maximum of 5% of the greater of those two amounts. For those with an annual income and net worth greater than $124,000, they are limited to investing 10% of the greater of the two amounts.
At the close of an offering, all investors whose funds have “cleared” by this time will be included in the disbursement. At this time, each investor will receive an email from StartEngine with their Countersigned Subscription Agreement, which will serve as their proof of purchase moving forward.
Please keep in mind that a company can conduct a series of “closes” or withdrawals of funds throughout the duration of the campaign. If you are included in that withdrawal period, you will be emailed your countersigned subscription agreement and proof of purchase immediately following that withdrawal.
StartEngine assists companies in raising capital, and once the offering is closed, we are no longer involved with whether the company chooses to list shares on a secondary market or what occurs thereafter. Therefore, StartEngine has no control or insight into your investment after the close of the live offering. In addition, we are not permitted to provide financial advice. You may want to contact a financial professional to discuss possible investment outcomes.
For Regulation Crowdfunding, investors are able to cancel their investment at any point throughout the campaign up until 48 hours before the closing of the offering. Note: If the company does a rolling close, they will post an update to their current investors, giving them the opportunity to cancel during this timeframe. If you do not cancel within this 5-day timeframe, your funds will be invested in the company, and you will no longer be able to cancel the investment. If your funds show as ‘Invested’ on your account dashboard, your investment can no longer be canceled.
For Regulation A+, StartEngine allows for a four-hour cancellation period. Once the four-hour window has passed, it is up to each company to set their own cancellation policy. You may find the company’s cancellation policy in the company’s offering circular.
Once your investment is canceled, there is a 10-day clearing period (from the date your investment was submitted). After your funds have cleared the bank, you will receive your refund within 10 business days.
Refunds that are made through ACH payments can take up to 10 business days to clear. Unfortunately, we are at the mercy of the bank, but we will do everything we can to get you your refund as soon as possible. However, every investment needs to go through the clearing process in order to be sent back to the account associated with the investment.
Both Title III (Regulation Crowdfunding) and Title IV (Reg A+) help entrepreneurs crowdfund capital investments from unaccredited and accredited investors. The differences between these regulations are related to the investor limitations, the differing amounts of money companies are permitted to raise, and differing disclosure and filing requirements. To learn more about Regulation Crowdfunding, click here, and for Regulation A+, click here.
William Coulter
2 years ago
Hey!, I didn't see in the info what wavelength your equipment produces. I'm considering it for my wife's use and my investment. Is it in the 600-825nm range? Thank you,
Show more
1
0